research use only
Cat.No.S6104
|
In vitro |
Ethanol : 100 mg/mL
DMSO
: 16 mg/mL
(37.14 mM)
Warmed with 60°C water bath;
Ultrasonicated;
Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 430.71 | Formula | C29H50O2 |
Storage (From the date of receipt) | 2 years 4°C(in the dark) liquid |
|---|---|---|---|---|---|
| CAS No. | 10191-41-0 | -- | |||
| Synonyms | (±)-Vitamin E acetate | SMILES | CC1=C(C2=C(CCC(O2)(C)CCCC(C)CCCC(C)CCCC(C)C)C(=C1O)C)C | ||
Read more about storage stability CAS number SMILES
(data from https://clinicaltrials.gov, updated on 2026-08-06)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06634056 | RECRUITING | Non-Small Cell Lung Cancer; Radiation Induced Lung Injury (RILI) |
University Health Network, Toronto |
2026-06-15 | PHASE2 |
| NCT06912763 | RECRUITING | Fibrosis Syndrome; Lymphedema; Head &Amp; Neck Cancer; Fibrosis |
M.D. Anderson Cancer Center |
2025-08-08 | PHASE2 |
| NCT06494111 | RECRUITING | Lymphedema; Fibrosis |
M.D. Anderson Cancer Center |
2025-02-13 | PHASE2 |
| NCT07796204 | NOT_YET_RECRUITING | Obesity; Type 2 Diabetes |
Pennington Biomedical Research Center |
2026-09-03 | |
| NCT05795647 | RECRUITING | Medication-related Osteonecrosis of the Jaw (MRONJ) |
University Hospital, Limoges |
2024-02-29 | PHASE2 |
| NCT07782411 | NOT_YET_RECRUITING | Obesity (BMI>30); Neuroinflammation |
Autonomous University of Morelos |
2026-08-10 |
Read more about Clinical Trials
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.